May 31-June 4 2024

The Art and Science of Cancer Care: From Comfort to Cure ASCO 2024, Chicago IL, USA

The ASCO Annual Meeting Program offers presentations on the latest research in cancer care. ​

Novocure presentations schedule

Monday, June 3

8:00AM -11:00AM (CDT)

Oral presentation

Results from METIS (EF-25), an International, Multicenter Phase III Randomized Study Evaluating the Efficacy and Safety of Tumor Treating Fields (TTFields) Therapy in NSCLC Patients with Brain Metastases

M.P. Mehta, V. Gondi, M.S. Ahluwalia, D. Roberge, R. Ilic, T.T. Sio, D.M. Trifiletti, T. Muanza, A.M. Krpan, N. Ramakrishna, J. Fiveash, P. Metellus, C.J. Wang, L. Feuvret, C. Freyschlag, T. Csőszi, P.D. Brown, M. Harat on behalf of the METIS study investigators

Monday, June 3

1:30PM - 4:30PM (CDT)

Poster

LUNAR-2: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant with Pembrolizumab and Platinum Based Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

Micheal Eaton, Manuel Cobo, Li Zhang, Maximilian Hochmair and Corey Langer

Saturday, June 1

9:00AM - 12:00PM (CDT)

Poster

Tumor Treating Fields (TTFields) therapy in patients with glioblastoma: Long-term survival results from TTFields in Germany in routine clinical care (TIGER) study

Oliver Bähr, Ghazaleh Tabatabai, Rainer Fietkau, Roland Goldbrunner, Martin Glas

 

Abstract

Deep learning for 4D modeling of glioblastoma multiforme with tumor treating fields (TTFields) therapy

Andres Felipe Guerrero Ramirez , Cynthia Crystal Tang , Xiao-Tang Kong , Daniela Annenelie Bota , Peter D. Chang

Novocure Websites

This website is intended for people seeking information on Novocure’s worldwide business.




Quick Links

Home
Clinical Research
Pre-Clinical Research
Congresses
Resources
Contact Us

All rights reserved.

MyLink, MyNovocure, Novocure, and Optune Gio are trademarks of Novocure GmbH.

All other trademarks, registered or unregistered, are the property of their respective owners.

MED-GL-PAN-2400032